1S,3R-ACPD has cataleptogenic effects and reverses MK-801- and less pronounced, D,L-amphetamine-induced locomotion

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 129-136

  Kronthaler, Ulrich O ^a   Schmidt, Werner J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Basal ganglia; Catalepsy; D,L amphetamine; Metabotropic glutamate receptors; MK 801; Open field

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; AMPHETAMINE; DIZOCILPINE; DOPAMINE RECEPTOR STIMULATING AGENT; GLUTAMATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CATALEPSY; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; CATALEPSY; CYCLOLEUCINE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; LOCOMOTION; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

EID: 0030571515     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00673-5     Document Type: Article

References (57)

1. Ambrosini, A., L. Bresciani, S. Fracchia, N. Brunello and G. Racagni, 1995, Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro, Mol. Pharmacol. 47, 1057.
2. Aylward, R.L. and S. Totterdell, 1993, Neurons in the ventral subiculum, amygdala and entorhinal cortex which project to the nucleus accumbens: Their input from somatostatin-immunoreactive boutons, J. Chem. Neuroanat. 6, 31.
3. Brog, J.S., A. Salyapongse, A.Y. Deutch and D.S. Zahm, 1993, The patterns of afferent innervation of the core and shell in the 'accumbens' part of the rat ventral striatum; Immunohistochemical detection of retrogradely transported fluoro-gold, J. Comp. Neurol. 338, 255.
4. Bruno, V., A. Copani., G. Battaglia, R. Raffaele, H. Shinozaki and F. Nicoletti, 1994, Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death, Eur. J. Pharmacol. 256, 109.
5. Bubser, M., U. Keseberg, P.K. Notz and W.J. Schmidt, 1992, Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats, Eur. J. Pharmacol. 229, 75.
6. Burns, L.H., T.W. Robbins and B.J. Everitt, 1993, Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine, Behav. Brain Res. 55, 167.
7. Cador, M., A.E. Kelley and L. Stinus, 1989, Exploration and its measurement. A psychopharmacological perspective, in: Neuromethods, eds. A.A. Boulton, G.B. Baker and A.J. Greenshaw (Humana Press, Clifton, NJ), Vol. 13, p. 95.
8. Calabresi, P., N.B. Mercuri and G. Bernardi, 1992, Activation of quisqualate metabotropic receptors reduces glutamate and GABA-mediated synaptic potentials in the rat striatum, Neurosci. Lett. 139, 41.
9. Carlsson, M. and A. Carlsson., 1989, The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice, J. Neural Transm. 75, 221.
10. Colwell, C.S. and M.S. Levine, 1994, Metabotropic glutamate receptors modulate N-methyl-D-aspartate receptor function in neostriatal neurons, Neuroscience 61, 497.
11. O'Connor, J.J., M.J. Rowan and R. Anwyl, 1994, Long-lasting enhancement of NMDA receptor-mediated synaptic transmission by metabotropic glutamate receptor activation, Nature 367, 557.
12. Conquet, F., Z.I. Bashir, C.H. Davies, H. Daniel, F. Ferraguti, F. Bordi, K. Franz-Bacon, A. Reggiani, V. Matarese, F. Condé, G.L. Collingridge and F. Crépel, 1994, Motor deficit and impairment of synaptic plasticity in mice lacking mGluR 1, Nature 372, 237.
13. Finch, D.M., J. Gigg, A.M. Tan and O.P. Kosoyan, 1995, Neurophysiology and neuropharmacology of projections from the entorhinal cortex to striatum in the rat, Brain Res, 670, 233.
14. French, E.D. and A. Ceci, 1990, Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons, Neurosci. Lett. 119, 159.
15. French, E.D., A. Mura and T. Wang, 1993, MK-801, phencyclidine (PCP) and PCP-like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists, Synapse 13, 108.
16. Fonnum, F., 1984, Glutamate: A neurotransmitter in mammalian brain, J. Neurochem. 42, 1.
17. Hannigan J.H., J.E. Springer and R.L. Isaacson, 1984, Differentiation of basal ganglia dopaminergic involvement in behavior after hippocampectomy, Brain Res. 291, 83.
18. Kaatz, K.W. and R.L. Albin, 1995, Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: A behavioral and fos immunohistochemical study, Neuroscience 66, 55.
19. Keele, N.B., V. Arvanov, K. Holmes and P. Shinnick-Gallagher, 1995, Agonist action of (RS)-methyl-4-carboxyphenylglycine (MCPG) in the amygdala, Neuroreport 6, 1058.
20. Kelley, A.E., 1993, Locomotor activity and exploration, in: Behavioural Neuroscience, ed. A. Sahgal, Vol. II (Oxford University Press, Oxford) p. 1.
21. Kelly, P.H., P.W. Seviour and S.D. Iversen, 1975, Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum, Brain Res. 94, 507.
22. Koch, M., 1993, Microinjections of the metabotropic glutamate receptor agonist, trans-(±)-1-amino-cyclopentane-1,3-dicarboxylate (trans-ACPD) into the amygdala increase the acoustic startle response of rats, Brain Res. 629, 176.
23. Koob, G.F., S.J. Riley, S.C. Smith and T.W. Robbins, 1978, Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity and amphetamine anorexia in the rat, J. Comp. Physiol. Psychol. 92, 917.
24. Kretschmer, B.D., 1994, Felbamate, an anticonvulsive drug, has antiparkinsonian potential in rats, Neurosci. Lett. 179, 115.
25. Kretschmer, B.D. and W.J. Schmidt, 1996, Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens, J. Neurosci. 16, 1561-1569.
26. Kretschmer, B.D., B. Winterscheid, W. Danysz and W.J. Schmidt, 1994, Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats, J. Neural Transm. Gen. Sect. 95, 123.
27. Liljequist, S., K. Ossowska, M. Grabowska-Anden and N.-E. Anden, 1991, Effects of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice, Eur. J. Pharmacol. 195, 55.
28. Liu, J. and B. Moghaddam, 1995, Regulation of glutamate efflux by excitatory amino acid receptors: Evidence for tonic inhibitory and phasic excitatory regulation, J. Pharmacol. Exp. Ther. 274, 1209.
29. Maj, J., H. Sowinska, L. Baran and J. Sarnek, 1974, Pharmacological evidence of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivate, Eur. J. Pharmacol. 26, 9.
30. Metha, A.K. and M.K. Ticku, 1990, Role of N-methyl-D-aspartate receptors in experimental catalepsy in rats, Life Sci. 46, 37.
31. Monaghan, D.T., R.J. Bridges and C.W. Cotman, 1989, The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system, Annu. Rev. Pharmacol. Toxicol. 29, 365.
32. Mittleman, G., P.A. LeDuc and I.Q. Wishaw, 1993, The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: An analogue of schizophrenia, Behav. Brain Res. 55, 253.
33. Osborne, P.G., W.T. O'Connor, K.L. Drew and U. Ungerstedt, 1990, An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats, J. Neurosci. Methods 34, 99.
34. Ouagazzal, A., A. Nieoullon and M. Amalric, 1993, Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats, Psychopharmacology 111, 427.
35. Paxinos, G. and C. Watson, 1986, The Rat Brain in Stereotaxic Coordinates (Academic Press, San Diego, CA).
36. Pin, J.-P. and R. Duvoisin, 1995, Review: Neurotransmitter receptors I. The metabotropic glutamate receptors, structure and functions, Neuropharmacology 34, 1.
37. Poncer, J.-C., H. Shinozaki and R. Miles, 1995, Dual modulation of synaptic inhibition by distinct metabotropic glutamate receptors in the rat hippocampus, J. Physiol. 485, 121.
38. Riedel, G., W. Wetzel, A.P. Kozikowski and K.G. Reymann, 1995, Block of spatial learning by mGluR agonist tADA in rats, Neuropharmacology 34, 559.
39. Sacaan, A.I., F.P. Bymaster and D.D. Schoepp, 1992a, Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine, J. Neurochem. 59, 245.
40. Sacaan, A.I. and D.D. Schoepp, 1992b, Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage, Neurosci. Lett. 139, 77.
41. Save, E., B. Poucet, N. Foreman and M.-C. Buhot, 1992, Object exploration and reactions to spatial and nonspatial changes in hooded rats following damage to parietal cortex and hippocampal formation, Behav. Neurosci. 106, 447.
42. Schmidt, W.J. and M. Bubser, 1989, Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats, Pharmacol. Biochem. Behav. 32, 621.
43. Schmidt, W.J. and D. Bury, 1988, Behavioural effects of the N-methyl-D-aspartate in the anterodorsal striatum of the rat, Life Sci. 43, 545.
44. Schmidt, W.J., M. Bubser and W. Hauber, 1992, Behavioural pharmacology of glutamate in the basal ganglia, J. Neural Transm. 38, 65.
45. Schoepp, D.D. and P.J. Conn, 1993, Metabotropic glutamate receptors in brain function and pathology, Trends Pharmacol. Sci. 14, 13.
46. Sladeczek, F., J.-P. Pin, M. Récasens, J. Bockaert and S. Weiss, 1985, Glutamate stimulates inositol phosphate formation in striatal neurons, Nature 317, 182.
47. Stahle, L., A.K. Collin and U. Ungerstedt, 1990, Effects of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindolacetic acid in rat striatum: A microdialysis study, Naunyn-Schmiedebergs Arch. Pharmakol. 342, 136.
48. Svensson, L., J. Zhang, K. Johannessen and J.A. Engel, 1994, Effect of local infusion of glutamate analogues into the nucleus accumbens of rats: An electrochemical and behavioural study, Brain Res. 643, 155.
49. Tanabe, Y., M. Masu, T. Ishii, R. Shigemoto and S. Nakanishi, 1992, A family of metabotropic glutamate receptors, Neuron 8, 169.
50. Tanabe, Y., A. Nomura, M. Masu, R. Shigemoto, N. Mizuno and S. Nakanishi, 1993, Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR 3 and mGluR 4, J. Neurosci. 13, 1372.
51. Testa, C.M., D.G. Standaert, A.B. Young and J.B. Penney Jr., 1994, Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat, J. Neurosci. 14, 3005.
52. Testa, C.M., D.G. Standaert, G.B. Landwehrmeyer, J.B. Penney Jr. and A.B. Young, 1995, Differential expression of mGluR 5 metabotropic glutamate receptor mRNA by rat striatal neurons, J. Comp. Neurol. 354, 241.
53. Tiedtke, P.I., C. Bischoff and W.J. Schmidt, 1990, MK-801-induced stereotypy and its antagonism by neuroleptic drugs, J. Neural Transm. 81, 173.
54. Tizzano, J.P., K.I. Griffey and D.D. Schoepp, 1995, Induction or protection of limbic seizures in mice by mGluR subtype selective agonists, Neuropharmacology 34, 1063.
55. Vázquez, E., I. Herrero, M.T. Miras-Portugal and J. Sánchez-Prieto, 1994, Facilitation of glutamate release by metabotropic glutamate receptors in hippocampal nerve terminals, Neurosci. Res. Commun. 15, 187.
56. 3H]glutamate binding sites in the rat brain, J. Neurochem. 63, 938.
57. Young, A.B. and G.E. Fagg, 1990, Excitatory amino acid receptors in the brain: Membrane binding and receptor autoradiographic approaches, Trends Pharmacol. Sci. 11, 126.